Cooperation Between MYC and β‐Catenin in Liver Tumorigenesis Requires Yap/Taz
| Autor: | Marco J. Morelli, Gianni Paolo Gamarra Figueroa, Diego Pasini, Giorgia Ceccotti, Fulvio Chiacchiera, Nina Tanaskovic, Francesca Biagioni, Marco Filipuzzi, Arianna Sabò, Giulia Brumana, Mirko Doni, Andrea Bisso, Vera Pendino, Daniela Olivero, Bruno Amati, Stefano Campaner |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
Adenomatous polyposis coli Cre recombinase Cell Cycle Proteins medicine.disease_cause Proto-Oncogene Proteins c-myc WNT Mice 03 medical and health sciences Liver Neoplasms Experimental 0302 clinical medicine Gene expression medicine Animals CTNNB1 mouse models Wnt Signaling Pathway beta Catenin 030304 developmental biology Adaptor Proteins Signal Transducing 0303 health sciences Hepatology biology hepatocellular carcinoma Wnt signaling pathway YAP-Signaling Proteins medicine.disease Mice Inbred C57BL 030104 developmental biology medicine.anatomical_structure Apoptosis 030220 oncology & carcinogenesis Hepatocyte Catenin Trans-Activators biology.protein Cancer research 030211 gastroenterology & hepatology Carcinogenesis Liver cancer |
| Zdroj: | Hepatology. 72:1430-1443 |
| ISSN: | 1527-3350 0270-9139 |
| DOI: | 10.1002/hep.31120 |
| Popis: | Background & AimsActivation of MYC and CTNNB1 (encoding β-catenin) can co-occur in liver cancer, but how these oncogenes cooperate in tumorigenesis remains unclear.Approach & ResultsWe generated a mouse model allowing conditional activation of MYC and WNT/β-catenin signaling (through either β-catenin activation or Apc loss) upon expression of CRE recombinase in the liver, and monitored their effects on hepatocyte proliferation, apoptosis, gene expression profiles and tumorigenesis. Conditional activation of WNT/β-catenin signaling strongly accelerated MYC-driven carcinogenesis in the mouse liver. Both pathways also cooperated in promoting cellular transformation in vitro, demonstrating their cell-autonomous action. Short-term induction of MYC and β-catenin in hepatocytes followed by RNA-seq profiling allowed the identification of a “Myc/β-catenin signature”, composed of a discrete set of Myc-activated genes whose expression increased in presence of active β-catenin. Notably this signature enriched for targets of Yap and Taz, two transcriptional co-activators known to be activated by WNT/β-catenin signaling, and to cooperate with MYC in mitogenic activation and liver transformation. Consistent with these regulatory connections, Yap/Taz accumulated upon Myc/β-catenin activation and were required not only for the ensuing proliferative response, but also for tumor cell growth and survival. Finally, the Myc/β-catenin signature was enriched in a subset of human hepatocellular carcinomas characterized by comparatively poor prognosis.ConclusionsYap and Taz mediate the cooperative action of Myc and β-catenin in liver tumorigenesis. This warrants efforts toward therapeutic targeting of Yap/Taz in aggressive liver tumors marked by elevated Myc/β-catenin activity. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text